Astrana Health, Inc. - Common Stock (ASTH) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2017 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ASTH on Nasdaq
Shares outstanding
49,931,653
Price per share
$24.81
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
26,740,469
Total reported value
$759,004,686
% of total 13F portfolios
0%
Share change
+666,882
Value change
+$21,223,465
Number of holders
184
Price from insider filings
$24.81
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Astrana Health, Inc. - Common Stock (ASTH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 12% +9.1% $193,828,926 -$6,179,448 6,234,446 -3.1% BlackRock, Inc. 31 Mar 2025
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp 11% -10% $190,668,814 -$21,759,767 6,132,802 -10% Allied Physicians of California, a Professional Medical Corporation 15 Feb 2025
VANGUARD GROUP INC 9.7% $148,578,224 4,833,384 The Vanguard Group 30 Jun 2025

As of 30 Sep 2025, 184 institutional investors reported holding 26,740,469 shares of Astrana Health, Inc. - Common Stock (ASTH). This represents 54% of the company’s total 49,931,653 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Astrana Health, Inc. - Common Stock (ASTH) together control 46% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 12% 6,007,634 +0.2% 0% $170,316,424
VANGUARD GROUP INC 9.5% 4,721,076 -2.3% 0% $133,842,504
STATE STREET CORP 3.2% 1,577,452 -1.5% 0% $44,720,764
DIMENSIONAL FUND ADVISORS LP 2.5% 1,234,721 -2.2% 0.01% $35,006,710
325 CAPITAL LLC 2.4% 1,193,953 +35% 10% $33,848,568
FMR LLC 2.2% 1,075,723 -9.6% 0% $30,496,737
GEODE CAPITAL MANAGEMENT, LLC 2% 1,015,956 -3.5% 0% $28,806,657
SteelPeak Wealth, LLC 1.2% 579,937 +7.8% 0.55% $16,441,214
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.1% 562,314 +12% 0% $15,941,602
JACOBS LEVY EQUITY MANAGEMENT, INC 1% 500,527 +19% 0.06% $14,189,940
MORGAN STANLEY 1% 497,867 -2.1% 0% $14,114,552
NorthCrest Asset Manangement, LLC 0.9% 448,381 -0.12% 0.32% $13,599,396
AMERIPRISE FINANCIAL INC 0.89% 442,314 +231% 0% $12,539,603
NORTHERN TRUST CORP 0.85% 423,249 -2.6% 0% $11,999,108
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 0.84% 421,710 +44% 0.04% $11,955,479
DIAMOND HILL CAPITAL MANAGEMENT INC 0.72% 361,264 +33% 0.05% $10,241,834
GOLDMAN SACHS GROUP INC 0.63% 316,996 +61% 0% $8,986,836
ROYCE & ASSOCIATES LP 0.52% 259,353 -16% 0.07% $7,352,658
Bank of New York Mellon Corp 0.49% 245,271 -2.6% 0% $6,953,441
Invesco Ltd. 0.49% 243,236 +1.3% 0% $6,895,740
PRINCIPAL FINANCIAL GROUP INC 0.45% 222,985 +0.27% 0% $6,321,624
AXA Investment Managers S.A. 0.42% 207,479 0% 0.02% $5,882,030
Pacer Advisors, Inc. 0.36% 181,910 0.01% $5,157,149
LPL Financial LLC 0.36% 178,034 0% $5,047,264
BANK OF AMERICA CORP /DE/ 0.35% 172,855 +100% 0% $4,900,439

Institutional Holders of Astrana Health, Inc. - Common Stock (ASTH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 698,466 $18,763,205 +$3,316,918 $24.81 11
2025 Q3 26,740,469 $759,004,686 +$21,223,465 $28.35 184
2025 Q2 25,772,189 $641,392,329 -$15,342,977 $24.88 161
2025 Q1 26,257,633 $814,637,037 +$5,865,025 $31.01 168
2024 Q4 26,057,899 $822,017,182 +$3,129,105 $31.53 176
2024 Q3 25,295,709 $1,465,673,085 +$131,412,432 $57.94 188
2024 Q2 22,983,767 $932,291,264 +$23,041,684 $40.56 168
2024 Q1 22,756,495 $955,394,010 +$25,359,616 $41.99 159
2023 Q4 114,800 $4,396,841 -$80,852 $38.30 2
2023 Q3 21,403,492 $660,548,952 +$22,050,116 $30.85 130
2023 Q2 20,655,484 $653,019,158 +$22,267,505 $31.60 127
2023 Q1 19,931,467 $726,862,882 +$14,696,395 $36.47 130
2022 Q4 19,395,528 $574,005,566 -$15,002,746 $29.59 125
2022 Q3 19,778,066 $771,195,551 +$71,525,764 $39.00 145
2022 Q2 17,732,418 $682,667,864 +$20,040,152 $38.59 123
2022 Q1 17,609,470 $853,298,644 +$10,435,409 $48.47 129
2021 Q4 17,108,614 $1,256,730,970 +$26,475,757 $73.48 140
2021 Q3 16,677,561 $1,518,905,911 +$596,793,968 $91.05 138
2021 Q2 10,230,884 $642,677,364 +$260,878,836 $62.81 102
2021 Q1 6,359,542 $172,275,211 +$32,027,520 $27.09 75
2020 Q4 5,211,121 $95,220,607 +$2,906,173 $18.27 59
2020 Q3 5,058,342 $90,681,749 +$15,494,209 $17.94 61
2020 Q2 4,190,060 $69,132,389 +$12,023,359 $16.50 47
2020 Q1 2,629,220 $33,971,795 -$1,792,066 $12.92 47
2019 Q4 3,558,294 $65,507,872 -$36,799,698 $18.41 53
2019 Q3 5,547,356 $97,743,067 +$47,839,934 $17.62 44
2019 Q2 2,842,354 $47,496,190 +$8,343,524 $16.71 35
2019 Q1 2,383,358 $43,665,062 -$549,740 $18.33 36
2018 Q4 2,404,181 $47,716,685 +$1,178,368 $19.85 38
2018 Q3 2,283,663 $50,401,877 -$7,472,994 $22.07 35
2018 Q2 2,608,798 $67,464,947 +$58,395,474 $25.86 31
2018 Q1 541,871 $8,642,000 +$7,424,175 $15.95 12
2017 Q4 50,403 $1,209,000 +$957,001 $23.97 6